Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis

Critical Care

Volumn 14, Issue 1, 2010, Pages

  Augustin, Pascal ^a   Kermarrec, Nathalie ^a   Muller Serieys, Claudette ^a   Lasocki, Sigismond ^a   Chosidow, Denis ^a   Marmuse, Jean Pierre ^a   Valin, Nadia ^b   Desmonts, Jean Marie ^a   Montravers, Philippe ^a  

^a BICHAT HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM CULTURE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIDRUG RESISTANCE; MYCOSIS; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REOPERATION; RISK FACTOR; TREATMENT OUTCOME; AGED; ANTIBIOTIC RESISTANCE; BACTERIUM; DRUG EFFECT; INTENSIVE CARE UNIT; MIDDLE AGED; PERITONITIS; POSTOPERATIVE COMPLICATION;

AGED; ANTI-BACTERIAL AGENTS; BACTERIA; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PERITONITIS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 77949483649     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc8877     Document Type: Article

References (27)

1. Roehrborn A, Thomas L, Potreck O, Ebener C, Ohmann C, Goretzki PE, Röher HD. The microbiology of postoperative peritonitis. Clin Infect Dis 2001, 33:1513-1519. 10.1086/323333, 11568851.
2. Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, Buchman T, Dellinger EP, Jernigan J, Gorbach S, Chow AW, Bartlett J, . Infectious Diseases Society of America Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003, 37:997-1005. 10.1086/378702, 14523762, Infectious Diseases Society of America.
3. Mazuski JE, Sawyer RG, Nathens AB, DiPiro JT, Schein M, Kudsk KA, Yowler C, . Therapeutic Agents Committee of the Surgical Infections Society The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect (Larchmt) 2002, 3:161-173. 10.1089/109629602761624171, 12542922, Therapeutic Agents Committee of the Surgical Infections Society.
4. Marshall JC, Innes M. Intensive care unit management of intra-abdominal infection. Crit Care Med 2003, 31:2228-2237. 10.1097/01.CCM.0000087326.59341.51, 12973184.
5. Marshall JC, Maier RV, Jimenez M, Dellinger EP. Source control in the management of severe sepsis and septic shock: An evidence-based review. Crit Care Med 2004, 32:S513-S526. 10.1097/01.CCM.0000143119.41916.5D, 15542959.
6. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437.
7. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596. 10.1097/01.CCM.0000217961.75225.E9, 16625125.
8. Montravers P, Gauzit R, Muller C, Marmuse JP, Fichelle A, Desmonts JM. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 1996, 23:486-494.
9. Seguin P, Laviolle B, Chanavaz C, Donnio PY, Gautier-Lerestif AL, Campion JP, Mallédant Y. Factors associated with multidrug-resistant bacteria in secondary peritonitis: impact on antibiotic therapy. Clin Microbiol Infect 2006, 12:980-985. 10.1111/j.1469-0691.2006.01507.x, 16961634.
10. Members of the SFM Antibiogram Comitee Comité de l'Antibiogramme de la Société Française de Microbiologie report 2003. Int J Antimicrob Agents 2003, 21:364-391. 10.1016/S0924-8579(03)00021-9, 12672587, Members of the SFM Antibiogram Comitee.
11. McCabe WR JG. Gram negative bacteremia. Arch Intern Med 1962, 110:847-864.
12. Polk HC, Lopez-Mayor JF. Postoperative wound infection: a prospective study of determinant factors and prevention. Surgery 1969, 66:97-103.
13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
14. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710. 10.1007/BF01709751, 8844239.
15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. Prognosis in acute organ-system failure. Ann Surg 1985, 202:685-693. 10.1097/00000658-198512000-00004, 1250999, 4073980.
16. DiNubile MJ, Chow JW, Satishchandran V, Polis A, Motyl MR, Abramson MA, Teppler H. Acquisition of resistant bowel flora during a double-blind randomized clinical trial of ertapenem versus piperacillin-tazobactam therapy for intraabdominal infections. Antimicrob Agents Chemother 2005, 49:3217-3221. 10.1128/AAC.49.8.3217-3221.2005, 1196251, 16048928.
17. Georges B, Conil JM, Dubouix A, Archambaud M, Bonnet E, Saivin S, Lauwers-Cancès V, Cristini C, Cougot P, Decun JF, Mathe O, Chabanon G, Marty N, Seguin T, Houin G. Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units. Crit Care Med 2006, 34:1636-1641. 10.1097/01.CCM.0000215517.51187.CA, 16557152.
18. Sotto A, Lefrant JY, Fabbro-Peray P, Muller L, Tafuri J, Navarro F, Prudhomme M, De La Coussaye JE. Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis. J Antimicrob Chemother 2002, 50:569-576. 10.1093/jac/dkf167, 12356803.
19. Dupont H, Carbon C, Carlet J. Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group. Antimicrob Agents Chemother 2000, 44:2028-2033. 10.1128/AAC.44.8.2028-2033.2000, 90009, 10898671.
20. Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, Dupont H. Clinical and microbiological profile of community-acquired and nosocomial intra-abdominal infections: results of the French prospective EBIIA study. J Antimicrob Chemother 2009, 63:785-794. 10.1093/jac/dkp005, 19196742.
21. Pieracci FM, Barie PS. Intra-abdominal infections. Curr Opin Crit Care 2007, 13:440-449. 10.1097/MCC.0b013e32825a6720, 17599016.
22. Solomkin JS. Antibiotic resistance in postoperative infections. Crit Care Med 2001, 29:N97-N99. 10.1097/00003246-200104001-00008, 11292883.
23. Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, Satishchandran V, McCarroll K, DiNubile MJ, Chow JW. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother 2006, 58:205-210. 10.1093/jac/dkl199, 16717055.
24. Krobot K, Yin D, Zhang Q, Sen S, Altendorf-Hofmann A, Scheele J, Sendt W. Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery. Eur J Clin Microbiol Infect Dis 2004, 23:682-687. 10.1007/s10096-004-1199-0, 15322931.
25. Koperna T, Schulz F. Prognosis and treatment of peritonitis. Do we need new scoring system?. Arch Surg 1996, 131:180-186.
26. Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, Hennequin C, Martin C. Candida as a risk factor for mortality in peritonitis. Crit Care Med 2006, 34:646-652. 10.1097/01.CCM.0000201889.39443.D2, 16505648.
27. Kusachi S, Sumiyama Y, Nagao J, Arima Y, Yoshida Y, Tanaka H, Nakamura Y, Saida Y, Watanabe M, Sato J. Drug susceptibility of isolates from severe postoperative intraperitoneal infections causing multiple organ failure. Surg Today 2005, 35:126-130. 10.1007/s00595-004-2910-6, 15674493.